Related Experiment Video
Updated: Oct 23, 2025
07:06
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
27.4K
Ulcerative Colitis in a COVID-19 Patient: A Case Report
Muhammet Fatih Aydın1, Hamit Taşdemir2
1Department of Gastroenterology, Altinbas University, Bahcelievler Medical Park Hospital, Istanbul, Turkey.
Summary
The novel coronavirus (COVID-19) may trigger ulcerative colitis, an inflammatory bowel disease. Patients with gastrointestinal symptoms post-COVID-19 should be evaluated for this condition.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Immunology
Background:
- COVID-19 pneumonia, a global pandemic, can affect multiple organs, including the gastrointestinal system.
- The coronavirus may influence the gut via angiotensin-converting enzyme-2 (ACE-2) expression.
- Limited data exist on the association between COVID-19 and inflammatory bowel diseases like ulcerative colitis.
Discussion:
- This report details a case of ulcerative colitis diagnosed in a male patient after COVID-19 pneumonia treatment.
- The patient presented with bloody diarrhea and abdominal pain, classic symptoms of ulcerative colitis.
- The findings suggest a potential causal link between COVID-19 infection and the onset of ulcerative colitis.
Key Insights:
- COVID-19 infection might act as a trigger for developing ulcerative colitis.
- Gastrointestinal symptoms following COVID-19 warrant thorough investigation for inflammatory bowel diseases.
- Early evaluation can lead to timely diagnosis and management of post-infectious ulcerative colitis.
Outlook:
- Further research is needed to elucidate the mechanisms linking COVID-19 and ulcerative colitis.
- Investigating ACE-2 receptor expression in the gut may provide insights into disease pathogenesis.
- Clinical vigilance for gastrointestinal manifestations in post-COVID-19 patients is crucial for comprehensive patient care.
